FSD Pharma
Dr. Chruscinski will be leading their clinical programs and helping lead their clinical trials as Associate Vice-President, Clinical Affairs. Dr. Chruscinski received his MD, and Ph.D. from Stanford University, followed by a residency in internal medicine at Stanford, a fellowship in cardiology at Stanford and Toronto General, and recently led two major clinical trials investigating tolerance in transplantation and new biomarkers discovery.
He is a board-certified cardiologist and carries an active medical license in Michigan.
This person is not in any offices
FSD Pharma
FSD Pharma is committed to the pursuit of developing innovative novel biotechnologies to bring advanced neurodegenerative and mental health treatments to market.